Evaluation of Surgery Versus Primary Chemotherapy in Resectable Signet Ring Cell Gastric Adenocarcinoma (ADCI002)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT01717924
Recruitment Status : Recruiting
First Posted : October 31, 2012
Last Update Posted : June 20, 2018
Federation Francophone de Cancerologie Digestive
Fédération de Recherche en Chirurgie (FRENCH)
Information provided by (Responsible Party):
University Hospital, Lille